Items where Subject is "diseases & disorders > cancer > cancer types > B cell lymphoma"

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Authors | Item Type
Jump to: | B | E | F | H | M | S | T | W
Number of items at this level: 11.

Ramiro, A. R., Jankovic, M., Callen, E., Difilippantonio, S., Chen, H. T., McBride, K. M., Eisenreich, T. R., Chen, J., Dickins, R. A., Lowe, S. W., Nussenzweig, A., Nussenzweig, M. C. (2006) Role of genomic instability and p53 in AID-induced c-myc-Igh translocations. Nature, 440 (7080). pp. 105-109. ISSN 00280836

B

Baumann, U., Targosz, B. S., Lemeer, S., Nikolova, V., Kratzat, S., Fernandez-Saiz, V., Reiter, C., Rudelius, M., Miething, C., Kuster, B., Peschel, C., Keller, U., Bassermann, F. (2011) SCF(Fbxo25) suppresses B cell lymphomagenesis by targeting Hax-1 for ubiquitin mediated proteasomal degradation. Onkologie, 34. p. 190. ISSN 0378-584X

E

Ellis, L., Lindemann, R., Newbold, A., Whitecross, K., Cluse, L., Pelligrini, M., Wei, A., Scott, C., Atadja, P., Lowe, S. W., Johnstone, R. W. (2007) Characterization of the apoptotic and therapeutic activities of the histone deacetylase inhibitors LAQ824 and LBH589 using a mouse model of B cell lymphoma. Molecular Cancer Therapeutics, 6 (12 Par). 3475S-3476S. ISSN 1535-7163

F

Fridman, J. S., Hernando, E., Hemann, M. T., de Stanchina, E., Cordon-Cardo, C., Lowe, S. W. (2003) Tumor promotion by Mdm2 splice variants unable to bind p53. Cancer Research, 63 (18). pp. 5703-5706. ISSN 0008-5472

H

He, L., Thomson, J. M., Hemann, M. T., Hernando-Monge, E., Mu, D., Goodson, S., Powers, S., Cordon-Cardo, C., Lowe, S. W., Hannon, G. J., Hammond, S. M. (2005) A microRNA polycistron as a potential human oncogene. Nature, 435 (7043). pp. 828-33. ISSN 0028-0836

M

Matthews, G. M., Cluse, L., Wang, E., Roth, M., Vakoc, C., Miao, W. Y., Rusche, J., Zuber, J., Johnstone, R. W. (2014) RNAi-mediated depletion of histone deacetylases highlights the potential for isoform-specific inhibitors in B-cell lymphoma and acute myeloid leukemia. Cancer Research, 74 (19). ISSN 0008-5472

Miething, C., Scuoppo, C., Lindqvist, L., Reyes, J., Ruse, C., Appelmann, I., Yoon, S., Krasnitz, A., Teruya-Feldstein, J., Pappin, D., Pelletier, J., Lowe, S. (2012) An oncogenome-based RNAi screen identifies a tumour suppressor network in B-cell lymphoma relying on the polyamine-hypusine axis. Onkologie, 35. p. 104. ISSN 0378-584X

S

Schmitt, C. A., McCurrach, M. E., de Stanchina, E., Wallace-Brodeur, R. R., Lowe, S. W. (1999) INK4a/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53. Genes and Development, 13 (20). pp. 2670-7. ISSN 0890-9369 (Print)

Schmitt, C. A., Rosenthal, C. T., Lowe, S. W. (2000) Genetic analysis of chemoresistance in primary murine lymphomas. Nature Medicine, 6 (9). pp. 1029-1035. ISSN 1078-8956

T

Tuveson, D., Rai, K. R. (2015) Augmenting NF-kappaB in poor-risk CLL: A general paradigm for other cancers? J Exp Med, 212 (6). pp. 830-1. ISSN 1540-9538 (Electronic)0022-1007 (Linking)

W

Wall, M., Poortinga, G., Stanley, K. L., Lindemann, R. K., Bots, M., Chan, C. J., Bywater, M. J., Kinross, K. M., Astle, M. V., Waldeck, K., Hannan, K. M., Shortt, J., Smyth, M. J., Lowe, S. W., Hannan, R. D., Pearson, R. B., Johnstone, R. W., McArthur, G. A. (2013) The mTORC1 inhibitor everolimus prevents and treats Eμ-Myc lymphoma by restoring oncogene-induced senescence. Cancer Discovery, 3 (1). pp. 82-95. ISSN 21598274

This list was generated on Tue Oct 24 07:24:30 2017 EDT.
CSHL HomeAbout CSHLResearchEducationNews & FeaturesCampus & Public EventsCareersGiving